BioCentury | Oct 12, 2015
Company News

Amyris, U.S. Department of Defense biomanufacturing news

...develop bio-based manufacturing tools and technologies to reduce the time and cost of bringing new molecules to market...
BioCentury | Jul 26, 2004
Strategy

The commercial imperative

Some companies don't realize they need a CEO with commercial experience until after they get their first molecule to market. But with more than 50 partnerships in place and its lead antibody heading for a...
BioCentury | Feb 26, 2001
Product Development

The Genentech way

...that biology, such as cell-based assays, will continue to be the primary tool for bringing molecules to market...
BioCentury | May 26, 1998
Company News

Molecules to Market diagnostics/imaging news

...diagnostics distributor, changed its name to Diagnology, the original name of the company’s marketing division. Molecules to Market...
BioCentury | Oct 20, 1997
Finance

European private rounds

...Microscience Ltd. £0.25M Merlin Ventures provided seed financing to developer of antimicrobial vaccines and drugs Molecules to Market...
Items per page:
1 - 5 of 5
BioCentury | Oct 12, 2015
Company News

Amyris, U.S. Department of Defense biomanufacturing news

...develop bio-based manufacturing tools and technologies to reduce the time and cost of bringing new molecules to market...
BioCentury | Jul 26, 2004
Strategy

The commercial imperative

Some companies don't realize they need a CEO with commercial experience until after they get their first molecule to market. But with more than 50 partnerships in place and its lead antibody heading for a...
BioCentury | Feb 26, 2001
Product Development

The Genentech way

...that biology, such as cell-based assays, will continue to be the primary tool for bringing molecules to market...
BioCentury | May 26, 1998
Company News

Molecules to Market diagnostics/imaging news

...diagnostics distributor, changed its name to Diagnology, the original name of the company’s marketing division. Molecules to Market...
BioCentury | Oct 20, 1997
Finance

European private rounds

...Microscience Ltd. £0.25M Merlin Ventures provided seed financing to developer of antimicrobial vaccines and drugs Molecules to Market...
Items per page:
1 - 5 of 5